Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Nucleai

Nucleai

Series A
Tel Aviv, IsraelJul 2020
AIHealthtech

Nucleai raised €5.8M in a Series A round in Jul 2020. The company is based in Tel Aviv, Israel. Investors in the round: Debiopharm Innovation Fund. Data as of 4 Nov 2026.

← Nucleai
Amount raised
€5.8M
€5,757,307
Native amount
6,500,000 USD
Stage
Series A
series a
Investors
1

Provenance & confidence

High confidence
Amount
6,500,000 USD
ECB-at-date → €5.8M · rate 1.129 on 2020-07-07
High confidence
Source

nocamels.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

1 named
Debiopharm Innovation Fund
Date
Jul 2020
Round type
series a
Amount (EUR)
€5.8M

Other rounds

same company

Related news